{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:17:41Z","timestamp":1789661861800,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T00:00:00Z","timestamp":1318636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00403-011-1179-z","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T16:11:37Z","timestamp":1318608697000},"page":"155-161","source":"Crossref","is-referenced-by-count":63,"title":["Comparison of the spread of three botulinum toxin type A preparations"],"prefix":"10.1007","volume":"304","author":[{"given":"Martina","family":"Kerscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wigger-Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,15]]},"reference":[{"key":"1179_CR1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","volume":"51","author":"B Ascher","year":"2004","unstructured":"Ascher B, Zakine B, Kestemont P, Baspeyras M, Bougara A, Santini J (2004) A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol 51:223\u2013233","journal-title":"J Am Acad Dermatol"},{"key":"1179_CR2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1524-4725.2009.01261.x","volume":"35","author":"B Ascher","year":"2009","unstructured":"Ascher B, Rzany BJ, Grover R (2009) Efficacy and safety of botulinum toxin type A in the treatment of lateral crow\u2019s feet: double-blind, placebo-controlled, dose-ranging study. Dermatol Surg 35:1478\u20131486","journal-title":"Dermatol Surg"},{"key":"1179_CR3","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","volume":"64","author":"R Benecke","year":"2005","unstructured":"Benecke R, Jost W, Kanovsky P, Ruzicka E, Comes G, Grafe S (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64:1949\u20131951","journal-title":"Neurology"},{"key":"1179_CR4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0190-9622(96)90016-X","volume":"34","author":"A Carruthers","year":"1996","unstructured":"Carruthers A, Kiene K, Carruthers J (1996) Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 34:788\u2013797","journal-title":"J Am Acad Dermatol"},{"key":"1179_CR5","first-page":"1","volume":"13","author":"A Carruthers","year":"2008","unstructured":"Carruthers A, Carruthers J (2008) Botulinum toxin products overview. Skin Ther Lett 13:1\u20135","journal-title":"Skin Ther Lett"},{"key":"1179_CR6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","volume":"46","author":"JA Carruthers","year":"2002","unstructured":"Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, Walker P, Eadie N (2002) A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 46:840\u2013849","journal-title":"J Am Acad Dermatol"},{"key":"1179_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1473-2165.2008.00361.x","volume":"7","author":"SH Cliff","year":"2008","unstructured":"Cliff SH, Judodihardjo H, Eltringham E (2008) Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study. J Cosmet Dermatol 7:50\u201354","journal-title":"J Cosmet Dermatol"},{"issue":"Suppl. 1","key":"1179_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17429590701523794","volume":"9","author":"AT Almeida De","year":"2007","unstructured":"de Almeida AT, De Boulle KJ (2007) Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications. J Cosmet Laser Ther 9(Suppl 1):17\u201322","journal-title":"J Cosmet Laser Ther"},{"key":"1179_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CIA.S9338","volume":"5","author":"K Boulle De","year":"2010","unstructured":"De Boulle K, Fragien S, Sommer B, Glogau R (2010) Treating glabellar lines with botulinum toxin type-A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction. Clin Interv Aging 5:101\u2013118","journal-title":"Clin Interv Aging"},{"key":"1179_CR10","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-34095-9","volume-title":"Botulinum toxin in aesthetic medicine","author":"M Maio De","year":"2007","unstructured":"De Maio M, Rzany B (2007) Botulinum toxin in aesthetic medicine. Springer, Heidelberg, Germany"},{"key":"1179_CR11","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/09638280701568296","volume":"29","author":"D Dressler","year":"2007","unstructured":"Dressler D, Benecke R (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 29:1761\u20131768","journal-title":"Disabil Rehabil"},{"key":"1179_CR12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","volume":"57","author":"KH Eisele","year":"2011","unstructured":"Eisele KH, Fink K, Vey M, Taylor HV (2011) Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon 57:555\u2013565","journal-title":"Toxicon"},{"key":"1179_CR13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1524-4725.2007.34008.x","volume":"34","author":"D Hexsel","year":"2008","unstructured":"Hexsel D, Dal\u2019Forno T, Hexsel C, Do Prado DZ, Lima MM (2008) A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A. Dermatol Sur 34:52\u201359","journal-title":"Dermatol Sur"},{"key":"1179_CR14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","volume":"140","author":"TS Hsu","year":"2004","unstructured":"Hsu TS, Dover JS, Arndt KA (2004) Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 140:1351\u20131354","journal-title":"Arch Dermatol"},{"key":"1179_CR15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/IAI.64.5.1589-1594.1996","volume":"64","author":"K Inoue","year":"1996","unstructured":"Inoue K, Fujinaga Y, Watanabe T, Ohyama T, Takeshi K, Moriishi K, Nakajima H, Inoue K, Oguma K (1996) Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun 64:1589\u20131594","journal-title":"Infect Immun"},{"key":"1179_CR16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00702-004-0234-8","volume":"112","author":"WH Jost","year":"2005","unstructured":"Jost WH, Kohl A, Brinkmann S, Comes G (2005) Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (Botox\u00ae) in healthy volunteers. J Neural Transm 112:905\u2013913","journal-title":"J Neural Transm"},{"key":"1179_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNF.0b013e3181b13308","volume":"32","author":"P Kanovsk\u00fd","year":"2009","unstructured":"Kanovsk\u00fd P, Slawek J, Denes Z, Platz T, Sassin I, Comes G, Grafe S (2009) Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity. Clin Neuropharmacol 32:259\u2013265","journal-title":"Clin Neuropharmacol"},{"key":"1179_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4725.2008.34375.x","volume":"35","author":"S Karsai","year":"2009","unstructured":"Karsai S, Raulin C (2009) Current evidence on the unit equivalence of different botulinum neurotoxin A formulations and recommendations for clinical practice in dermatology. Dermatol Surg 35:1\u20138","journal-title":"Dermatol Surg"},{"key":"1179_CR19","doi-asserted-by":"crossref","first-page":"413e","DOI":"10.1097\/PRS.0b013e318170813c","volume":"121","author":"A Klein","year":"2008","unstructured":"Klein A, Carruthers A, Fagien S, Lowe NJ (2008) Comparisons among botulinum toxins: an evidence-based review. Plast Reconstr Surg 121:413e\u2013422e","journal-title":"Plast Reconstr Surg"},{"key":"1179_CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1524-4725.2005.31070","volume":"31","author":"NJ Lowe","year":"2005","unstructured":"Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N (2005) Double-blind, randomised, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow\u2019s feet. Dermatol Surg 31:257\u2013262","journal-title":"Dermatol Surg"},{"key":"1179_CR21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF01652699","volume":"101","author":"V Minor","year":"1928","unstructured":"Minor V (1928) Ein neues verfahren zu der klinischen untersuchung der schwei\u03b2absonderung. Deutsch Z Nervenhlk 101:302\u2013308","journal-title":"Deutsch Z Nervenhlk"},{"key":"1179_CR22","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1524-4725.2006.32332.x","volume":"33","author":"G Monheit","year":"2007","unstructured":"Monheit G, Carruthers A, Brandt F, Rand R (2007) A randomised, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg 33:S51\u2013S59","journal-title":"Dermatol Surg"},{"key":"1179_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","volume":"113","author":"P Roggenk\u00e4mper","year":"2006","unstructured":"Roggenk\u00e4mper P, Jost W, Bihari K, Comes G, Grafe S (2006) Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113:303\u2013312","journal-title":"J Neural Transm"},{"key":"1179_CR24","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1524-4725.2006.32330.x","volume":"33","author":"AR Trindade de Almeida","year":"2007","unstructured":"Trindade de Almeida AR, Marques E, de Almeida J, Cunha T, Boraso R (2007) Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg 33:S37\u2013S43","journal-title":"Dermatol Surg"},{"key":"1179_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.WNF.0000240951.18821.50","volume":"30","author":"K Wohlfarth","year":"2007","unstructured":"Wohlfarth K, Muller C, Sassin I, Comes G, Grafe S (2007) Neurophysiological double-blind trial of a botulinum neurotoxin type A free of complexing proteins. Clin Neuropharmacol 30:86\u201394","journal-title":"Clin Neuropharmacol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-011-1179-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-011-1179-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-011-1179-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T01:12:32Z","timestamp":1593133952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-011-1179-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,15]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1007\/s00403-011-1179-z","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,15]]}}}